HOOKIPA Pharma raises $37.4M in Series D Financing

HOOKIPA Pharma, a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infect...

February 26, 2019 | Tuesday | News
Marinomed receives EUR 15M EIB financing

The European Investment Bank (EIB) is providing EUR 15 million to Marinomed Biotech AG, a Vienna- based Biopharmaceutica...

February 26, 2019 | Tuesday | News
FDA & Flatiron Health expand Data Cancer Research collaboration

Flatiron Health and the Information Exchange and Data Transformation (INFORMED) Program at the U.S. Food and Drug Admini...

February 27, 2019 | Wednesday | News
Novartis to license Akcea-Ionis cardiac disease drug

Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals announced that Novartis has exercised its option to licen...

February 26, 2019 | Tuesday | News
Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial

Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drug...

February 25, 2019 | Monday | News
GE to sell Biopharma business for $21.4B to Danaher

GE has announced a definitive agreement to sell its BioPharma business to Danaher Corporation for a total consideration ...

February 26, 2019 | Tuesday | News
Sysmex Inostics' OncoBEAM shows superior performance in mutation detection for HCC

Data recently published in Clinical Cancer Research demonstrate the advantages of using an ultra-high sensitiv...

February 25, 2019 | Monday | News
EC approves Pfizer's ZIRABEV, a biosimilar to Avastin

Pfizer recently announced that the European Commission (EC) has approved ZIRABEV for the treatment of metastatic ca...

February 25, 2019 | Monday | News
Roche to acquire Spark Therapeutics for $ 4.3B

Roche and Spark Therapeutics have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeuti...

February 25, 2019 | Monday | News
AbbVie and Voyager Therapeutics announce collaboration

AbbVie, biopharmaceutical company and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing ...

February 25, 2019 | Monday | News
FDA grants priority review to Merck's application for KEYTRUDA in SCLC

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supp...

February 22, 2019 | Friday | News
Teva to apply Insilico's predictive Digital Twins for biopharmaceutical production

Insilico Biotechnology AG and Teva Pharmaceutical Industries Ltd. have announced an agreement to apply Insilico’s ...

February 22, 2019 | Friday | News
WHO releases report on Global Health Expenditure

Spending on health is growing faster than the rest of the global economy, accounting for 10% of global gross domestic pr...

February 22, 2019 | Friday | News
Merck to acquire Immune Design in a $300M deal

Merck , known as MSD outside the United States and Canada, and Immune Design, has announced that the companies have ente...

February 22, 2019 | Friday | News
Mallinckrodt presents analysis results for Therakos against aGvHD

Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its compan...

February 21, 2019 | Thursday | News
Takeda, Microsoft, EURORDIS release action plan to end the diagnostic odyssey

The Global Commission to End the Diagnostic Odyssey for Children , co-chaired by Takeda, Microsoft and EURORDIS-Rare Dis...

February 21, 2019 | Thursday | News
Aveanna Healthcare to acquire Maxim Healthcare Services' Home Healthcare Division

Aveanna Healthcare, a leading home healthcare company has announced that it has entered into a definitive agreement to a...

February 20, 2019 | Wednesday | News
AGC Biologics, Calypso Biotech sign pact for cGMP manufacturing

AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and Calypso Biotech B.V...

February 21, 2019 | Thursday | News
Novartis receives FDA approval for Egaten

Novartis has announced that the US Food and Drug Administration (FDA) approval of Egaten (triclabendazole) for the treat...

February 20, 2019 | Wednesday | News
Merck gets first U.S. Patent for improved CRISPR technology

Merck, a leading science and technology company and leader in genome editing, announced that the United States Pate...

February 20, 2019 | Wednesday | News
Qiagen to advance fight against antibiotic resistant pathogens

QIAGEN N.V. has announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V., to develop innovative bioi...

February 20, 2019 | Wednesday | News
FDA & NIH-funded study finds genetic vulnerability to menthol cigarette use

A genetic variant found only in people of African descent significantly increases a smoker’s preference for cigare...

February 19, 2019 | Tuesday | News
Saniona announces succesful completion of preclinical development of SAN711

Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical de...

February 19, 2019 | Tuesday | News
Healthcare Artificial Intelligence market to hit $13B by 2025

Europe healthcare artificial intelligence market witnessed 41.8% growth throughout the analysis period. Adoption of...

February 19, 2019 | Tuesday | News
WHO-ITU standard to prevent hearing loss among 1.1 billion young people

Ahead of World Hearing Day (3 March), the World Health Organization (WHO) and the International Telecommunication Union ...

February 19, 2019 | Tuesday | News